Of note, this tendency was also apparent for murine glioma cells with a lower proliferative potential and different genetic background—namely, PNMG106 cells with homozygous deletion of Tp53 and Nf1 (Fig. S4 and Video S1). This evidence concerns the gene TP53 and central nervous system cancer.